VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials
VESPRO: An Individual Patient Data Prospective Meta-Analysis of Selective Internal Radiation Therapy Versus Sorafenib for Advanced, Locally Advanced, or Recurrent Hepatocellular Carcinoma of the SARAH and SIRveNIB Trials
Val Gebski
1
, MStat ;
Emma Gibbs
2
, MSc ;
Mihir Gandhi
3
, MSc ;
Gilles Chatellier
4
, PhD ;
Aurelia Dinut
4
, PhD ;
Helena Pereira
4
, MSc ;
Pierce KH Chow
5
, PhD ;
Valérie Vilgrain
6
, PhD
1
NHMRC Clinical Trials Centre, University Sydney, Camperdown, Australia
2
NHMRC Clinical Trials Centre, University of Sydney, Camperdown, Australia
3
Biostatistics, Singapore Clinical Research Institute, Singapore, Singapore
4
Clinical Research Unit, Assistance Publique, Hôpitaux de Paris, Paris, France
5
Division of Surgical Oncology, National Cancer Centre Singapore, Singapore, Singapore
6
Department of Radiology, Assistance Publique, Hôpitaux de Paris, Paris, France
Corresponding Author:
-
Val Gebski, MStat
-
NHMRC Clinical Trials Centre
-
University Sydney
-
Level 5 MFB Building
-
92-94 Parramatta Road
-
Camperdown, 2050
-
Australia
-
Phone:
61 2 9562 5328
-
Fax: 61 2 9565 1863
-
Email: val@ctc.usyd.edu.au